Evidence map›Paper›PMID 36566187›Full record

ArticleBMC medical imaging2022

Performance of

Yutang Yao, Xiaofei Tan, Wenya Yin, Ying Kou, Xiaoxiong Wang, Xiao Jiang, Shirong Chen, Yongli Liu, Jun Dang, Jun Yin and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC medical imaging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Comparative Insights intoMolecular imaging and radionuclide therapy · 2026
    Article
  2. Review
  3. Diagnostic value of [Frontiers in oncology · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. The relationship between gadolinium enhancement and [18 F]fluorothymidine uptake in brain lesions with the use of hybrid PET/MRI.Cancer imaging : the official publication of the International Cancer Imaging Society · 2024
    Article
  10. [Nuclear medicine and molecular imaging · 2024
    Article
  11. Theranostics · 2024
    Article
  12. Radiosynthesis andFrontiers in oncology · 2024
    Article
  13. Article
  14. Comparative analysis of two timepoints on [European journal of hybrid imaging · 2023
    Article
  15. FAPI PET/CT Imaging-An Updated Review.Diagnostics (Basel, Switzerland) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Yutang Yao *Department of Nuclear Medicine, Sichuan Cancer Hospital&Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, No.55, Section 4, South People's Road, Sichuan, 610041, Chengdu, China.
Xiaofei Tan *Department of Nuclear Medicine, Sichuan Cancer Hospital&Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, No.55, Section 4, South People's Road, Sichuan, 610041, Chengdu, China.
Wenya YinDepartment of Radiation Oncology, Sichuan Cancer Hospital&Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, No.55, Section 4, South People's Road, 610041, Chengdu, China.
Ying KouDepartment of Nuclear Medicine, Sichuan Cancer Hospital&Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, No.55, Section 4, South People's Road, Sichuan, 610041, Chengdu, China.
Xiaoxiong WangDepartment of Nuclear Medicine, Sichuan Cancer Hospital&Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, No.55, Section 4, South People's Road, Sichuan, 610041, Chengdu, China.
Xiao JiangDepartment of Nuclear Medicine, Sichuan Cancer Hospital&Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, No.55, Section 4, South People's Road, Sichuan, 610041, Chengdu, China.
Shirong ChenDepartment of Nuclear Medicine, Sichuan Cancer Hospital&Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, No.55, Section 4, South People's Road, Sichuan, 610041, Chengdu, China.
Yongli LiuDepartment of Nuclear Medicine, Sichuan Cancer Hospital&Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, No.55, Section 4, South People's Road, Sichuan, 610041, Chengdu, China.
Jun DangDepartment of Nuclear Medicine, Sichuan Cancer Hospital&Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, No.55, Section 4, South People's Road, Sichuan, 610041, Chengdu, China.
Jun YinDepartment of Radiation Oncology, Sichuan Cancer Hospital&Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, No.55, Section 4, South People's Road, 610041, Chengdu, China. gzyinjun@163.com.
Zhuzhong ChengDepartment of Nuclear Medicine, Sichuan Cancer Hospital&Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, No.55, Section 4, South People's Road, Sichuan, 610041, Chengdu, China. chengzhuzhong@163.com.
University of Electronic Science and Technology of China · CNSichuan Cancer Hospital · CN

Funding

Sichuan Cancer Hospital Outstanding Youth Funding YB2021029Sichuan Medicine Research Project S21030Sichuan Province Science and Technology Support Program 2020YFS0417Sichuan Province Science and Technology Support Program 2021YFS0227The Education Program of Sichuan Province 18ZB0241
6 · The paper itself

Abstract

backgroundWe aimed to determine the performance of

methodsTwelve glioblastoma patients having undergone incomplete surgical resection or biopsy were examined with

results

conclusion

Indexed as

GlioblastomaRadiologyBiopsyFluorodeoxyglucose F18HumansIvermectinPilot ProjectsPositron Emission Tomography Computed TomographyabamectinFluorodeoxyglucose F18IvermectinFAPIGlioblastomaMetabolic parametersMolecular expressionMRIPET/CT

Identifiers

PMID36566187
PMCPMC9789562
OpenAlexW4313249075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.